Aldebaran Capital, LLC An2 Therapeutics, Inc. Transaction History
Aldebaran Capital, LLC
- $106 Billion
- Q1 2025
A detailed history of Aldebaran Capital, LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Aldebaran Capital, LLC holds 406,623 shares of ANTX stock, worth $483,881. This represents 0.52% of its overall portfolio holdings.
Number of Shares
406,623
Previous 343,684
18.31%
Holding current value
$483,881
Previous $474 Million
16.6%
% of portfolio
0.52%
Previous 0.45%
Shares
3 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
13.7MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$6.84 Million6.33% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.56 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.23 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1MShares$1.19 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY581KShares$691,2150.89% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $23.1M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...